The round also includes existing investors Oak HC/FT and Cigna Ventures, as well as K2 HealthVentures and a strategic investment from Blue Shield of California. The funding round will enable Cricket Health's rapid expansion to support growing demand for its proven care model for people with kidney disease across the United States.

Cricket Health is an industry-leading provider of value-based kidney care with a clinically-proven approach to managing chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Cricket Health helps payers and providers shift their entire approach to kidney disease upstream, enabling them to intervene early and deliver stage-specific care to those who need it most, ultimately reducing costs and improving kidney disease outcomes. Cricket Health uses the StageSmart™ machine learning model and predicted GFR (pGFR™) to risk stratify a patient population across each stage of kidney disease with 96 percent accuracy for people with stage 3b and beyond and then delivers individualized care through its comprehensive patient support service, MyCricket™. Cricket Health members have access to educational resources, peer support, and a multidisciplinary care team in person, by telephone, and virtually.